Partnering

Collaborating with ProteinQure

If you need a peptide ligand or want to optimize an existing one, we can solve your peptide discovery projects with our computational design platform, ProteinStudio™. This technology leverages access to state-of-the-art AI models for de novo peptide design and drug-like property prediction that support 3,500+ non-natural amino acids.

Our partners have targets in mind and we help them find leads. All our partnerships are centered around one or more primary approaches to peptide drug design:

Lead Optimization

Enhance the therapeutic potential of your peptides and proteins with our specialized lead optimization techniques, ensuring stability, activity, and targeted delivery in your drug discovery efforts.

AI-Guided Library Design

We design synthetic peptide libraries (10^6 to 10^12) with high-stability scaffolds, variable size (10-30 amino acids), and enhanced drug-like properties (linear, cyclic, serum-stable, soluble, etc).

De Novo Peptide Design

ProteinStudio™ enables us to design both natural and synthetic protein ligands with unprecedented drug-like properties, including efficacy, selectivity, solubility, and stability. Novel de novo ligands can be designed even in cases with no known hits.

Proudly Partnering With
AI-guided library design
Lead optimization
De novo peptide design
De novo peptide design
AI-guided library design
De novo peptide design
Lead optimization
Next-gen protein modalities

Thanks and acknowledgments

We would like to acknowledge the generous funding from the National Research Council of Canada Industrial Research Assistance Program (IRAP), the Ontario Center for Innovation (OCI), the Canada Digital Adoption Program (CDAP) as well as FedDev Ontario, which are enabling several of our internal drug discovery projects.
Partner with us

Let’s work together

We are always looking for visionary partners, especially those focused on peptide therapeutics and peptide-based drug delivery. Let’s collaborate to accelerate innovative treatments. If you’re interested in partnering with us, please reach out at:

 

partnering@proteinqure.com

GET IN TOUCH
Testimonials
The combination of designed peptide libraries, based on ProteinQure's computational methods, with our advanced capabilities in display technologies will help us harness the potential of this therapeutic class.
Tristan Vaughan
VP of Antibody Discovery & Protein Engineering, AstraZeneca
Picture CreditPic: Sphere Fluidics Limited